Company Profile:
Business Nature: Manufacturing Facility and Incubator
Company Profile:
Honam Pharmed Accelerator is a specialized biotechnology and pharmaceutical enterprise located in Iran. The company operates as a high-tech manufacturing facility and an industrial accelerator dedicated to the development, formulation, and production of advanced pharmaceutical products. By integrating research and development with commercial-scale manufacturing, the company focuses on bridging the gap between innovative laboratory discoveries and market-ready medical solutions. Their operations encompass standardized production lines, quality control systems, and the commercialization of pharmaceutical raw materials and finished dosage forms.
Classification: Manufacturer (Factory)
Enterprise Products
Honam Pharmed Accelerator specializes in the development, production, and distribution of various pharmaceutical and health-related products. Their portfolio generally includes the following categories:
Pharmaceutical Finished Products
They produce a range of generic medications and specialized formulations, including tablets, capsules, and syrups, covering therapeutic areas such as cardiovascular health, metabolic disorders, and pain management.
Nutraceuticals and Supplements
The company develops dietary supplements, vitamins, and minerals designed to support general health, immune function, and specific physiological needs.
Dermatological and Cosmetic Products
They offer a line of dermo-cosmetic products, including creams, lotions, and ointments focused on skin repair, hydration, and dermatological care.
Raw Materials and Active Pharmaceutical Ingredients (APIs)
The company facilitates the supply and distribution of high-quality raw materials and APIs required for pharmaceutical manufacturing processes.
Medical Equipment and Diagnostic Kits
They are involved in the distribution of laboratory equipment and diagnostic kits used for clinical testing and research purposes.
Biotechnology Products
The accelerator focuses on fostering and distributing innovative biopharmaceutical products, including biosimilars and advanced therapeutic agents.